PHX — Pharmx Technologies Balance Sheet
0.000.00%
Last trade - 00:00- AU$55.06m
- AU$50.77m
- AU$6.78m
- 89
- 43
- 94
- 86
Annual balance sheet for Pharmx Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.32 | 6.48 | 5.76 | 12.8 | 13.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.53 | 2.41 | 2.63 | 2.6 | 3.15 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9.84 | 10.4 | 8.59 | 22.6 | 16.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.23 | 0.791 | 0.603 | 0.047 | 0.243 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 19.2 | 31.3 | 30.8 | 36.5 | 29.9 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.48 | 6.39 | 5.11 | 12.3 | 11.9 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.98 | 8.42 | 7.57 | 14.3 | 13.9 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 13.2 | 22.9 | 23.2 | 22.2 | 16 |
| Total Liabilities & Shareholders' Equity | 19.2 | 31.3 | 30.8 | 36.5 | 29.9 |
| Total Common Shares Outstanding |